{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:47:23Z","timestamp":1761511643646,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1023\/a:1006313611677","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T20:36:27Z","timestamp":1040502987000},"page":"95-107","source":"Crossref","is-referenced-by-count":60,"title":["UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines"],"prefix":"10.1007","volume":"18","author":[{"given":"Anne","family":"Monks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik D.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Vaigro-Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis D.","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward A.","family":"Sausville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"260334_CR1","first-page":"4888","volume":"51","author":"S Akinaga","year":"1991","unstructured":"Akinaga S, Gomi K, Morimoto M, Tamaoki T, Okabe M: Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models. Cancer Res 51: 4888\u20134892, 1991","journal-title":"Cancer Res"},{"key":"260334_CR2","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.7164\/antibiotics.40.1782","volume":"40","author":"I Takahashi","year":"1987","unstructured":"Takahashi I, Kobayashi E, Asano K, Yoshida M, Nakano H: UCN-01, a selective inhibitor of protein kinase C from Streptomyces. J Antibot (Tokyo) 40: 1782\u20131784, 1987","journal-title":"J Antibot (Tokyo)"},{"key":"260334_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7164\/antibiotics.42.571","volume":"42","author":"I Takahashi","year":"1989","unstructured":"Takahashi I, Saitoh Y, Yoshida M, Sano H, Nakano H, Morimoto M, Tamaoki T: UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities. J Antibiot (Tokyo) 42: 571\u2013576, 1989","journal-title":"J Antibiot (Tokyo)"},{"key":"260334_CR4","first-page":"927","volume":"6","author":"Q Wang","year":"1995","unstructured":"Wang Q, Worland PJ, Clark JL, Carlson BA, Sausville EA: Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ 6: 927\u2013936, 1995","journal-title":"Cell Growth Differ"},{"key":"260334_CR5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/bjc.1995.137","volume":"71","author":"C Courage","year":"1995","unstructured":"Courage C, Budworth J, Gescher A: Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br J Cancer 71: 697\u2013704, 1995","journal-title":"Br J Cancer"},{"key":"260334_CR6","first-page":"2081","volume":"53","author":"CM Seynaeve","year":"1993","unstructured":"Seynaeve CM, Stetler-Stevenson M, Sebers S, Kaur G, Sausville EA, Worland PJ: Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells. Cancer Res 53: 2081\u20132086, 1993","journal-title":"Cancer Res"},{"key":"260334_CR7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/bjc.1996.517","volume":"74","author":"C Courage","year":"1996","unstructured":"Courage C, Snowden R, Gescher A: Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells. Br J Cancer 74: 1199\u20131205, 1996","journal-title":"Br J Cancer"},{"key":"260334_CR8","first-page":"1495","volume":"57","author":"T Akiyama","year":"1997","unstructured":"Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S: G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21\/Cip1\/WAF1\/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Cancer Res 57: 1495\u20131501, 1997","journal-title":"Cancer Res"},{"key":"260334_CR9","first-page":"927","volume":"6","author":"Q Wang","year":"1995","unstructured":"Wang Q, Worland PJ, Clark JL, Carlson BA, Sausville EA: Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ 6: 927\u2013936, 1995","journal-title":"Cell Growth Differ"},{"key":"260334_CR10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1006\/bbrc.1996.0310","volume":"219","author":"K Kawakami","year":"1996","unstructured":"Kawakami K, Futami H, Takahara J, Yamaguchi K: UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinasas and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun 219: 778\u2013783, 1996","journal-title":"Biochem Biophys Res Commun"},{"key":"260334_CR11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000227626","volume":"53","author":"E Shimizu","year":"1996","unstructured":"Shimizu E, Zhao MR, Nakanishi H, Yamamoto A, Yoshida S, Takada M, Ogura T, Sone S: Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines. Oncology 53: 494\u2013504, 1996","journal-title":"Oncology"},{"key":"260334_CR12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/jnci\/88.14.956","volume":"88","author":"Q Wang","year":"1996","unstructured":"Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O'Connor PM: UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 88: 956\u2013965, 1996","journal-title":"J Natl Cancer Inst"},{"key":"260334_CR13","first-page":"791","volume":"2","author":"RT Bunch","year":"1996","unstructured":"Bunch RT, Eastman A: Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor. Clin Cancer Res 2: 791\u2013797, 1996","journal-title":"Clin Cancer Res"},{"key":"260334_CR14","first-page":"4029","volume":"57","author":"RG Shao","year":"1997","unstructured":"Shao RG, Cao CX, Shimizu T, O'Connor PM, Kohn KW, Pommier Y: Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res 57: 4029\u20134035, 1997","journal-title":"Cancer Res"},{"key":"260334_CR15","first-page":"779","volume":"8","author":"RT Bunch","year":"1997","unstructured":"Bunch RT, Eastman A: 7-hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells. Cell Growth Differ 8: 779\u2013788, 1997","journal-title":"Cell Growth Differ"},{"key":"260334_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00685833","volume":"32","author":"S Akinaga","year":"1993","unstructured":"Akinaga S, Nomura K, Gomi K, Okabe M: Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C. Cancer Chemother Pharmacol 32: 183\u2013189, 1993","journal-title":"Cancer Chemother Pharmacol"},{"key":"260334_CR17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3171\/jns.1996.84.6.1024","volume":"84","author":"IF Pollack","year":"1996","unstructured":"Pollack IF, Kawecki S, Lazo JS: Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor. J Neurosurg 84: 1024\u20131032, 1996","journal-title":"J Neurosurg"},{"key":"260334_CR18","first-page":"2089","volume":"3","author":"A Husain","year":"1997","unstructured":"Husain A, Yan XJ, Rosales N, Aghajanian C, Schwartz GK, Spriggs DR: UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum (II) independent of p53 status. Clin Cancer Res 3: 2089\u20132097, 1997","journal-title":"Clin Cancer Res"},{"key":"260334_CR19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0360-3016(97)00549-X","volume":"39","author":"E Tsuchida","year":"1997","unstructured":"Tsuchida E, Urano M: The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma. Int J Radiat Oncol Biol Phys 39: 1153\u20131161, 1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"260334_CR20","first-page":"2201","volume":"4","author":"CT Hsueh","year":"1998","unstructured":"Hsueh CT, Kelsen D, Schwartz GK: UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner. Clin Cancer Res 4: 2201\u20132206, 1998","journal-title":"Clin Cancer Res"},{"key":"260334_CR21","first-page":"105","volume":"36","author":"DJ Bauer","year":"1954","unstructured":"Bauer DJ: The antiviral and synergic actions of isatin thiosemicarbazone and certain phenoxypyrimidines in vaccinia infection in mice. Br J Exp Pathology 36: 105\u2013109, 1954","journal-title":"Br J Exp Pathology"},{"key":"260334_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","volume":"14","author":"MN Prichard","year":"1990","unstructured":"Prichard MN, Shipman C Jr: A three-dimensional model to analyze drug-drug interactions. Antiviral Res 14: 181\u2013205, 1990","journal-title":"Antiviral Res"},{"key":"260334_CR23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","volume":"83","author":"A Monks","year":"1997","unstructured":"Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K, Vistica D, Hose C, Langley J, Cronice P, Vaigro-Wolff A: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cells lines. J Natl Cancer Inst 83: 757\u2013766, 1997","journal-title":"J Natl Cancer Inst"},{"key":"260334_CR24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107\u20131112, 1990","journal-title":"J Natl Cancer Inst"},{"key":"260334_CR25","first-page":"3242","volume":"49","author":"IL Dale","year":"1989","unstructured":"Dale IL, Bradshaw TD, Gescher A, Pettit GR: Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Cancer Res 49: 3242\u20133245, 1989","journal-title":"Cancer Res"},{"key":"260334_CR26","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.91.20.9480","volume":"91","author":"PM O'Connor","year":"1994","unstructured":"O'Connor PM, Ferris DK, Hoffmann I, Jackman J, Draetta G, Kohn KW: Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc Natl Acad Sci 91: 9480\u20139484, 1994","journal-title":"Proc Natl Acad Sci"},{"key":"260334_CR27","first-page":"151","volume":"29","author":"PM O'Connor","year":"1997","unstructured":"O'Connor PM: Mammalian G1 and G2 phase checkpoints. Cancer Surv 29: 151\u2013182, 1997","journal-title":"Cancer Surv"},{"key":"260334_CR28","doi-asserted-by":"crossref","first-page":"33455","DOI":"10.1074\/jbc.273.50.33455","volume":"273","author":"L Yu","year":"1998","unstructured":"Yu L, Orlandi L, Wang P, Orr MS, Senderowicz AM, Sausville EA, Silverstrini R, Watanabe N, Piwnica-Worms H, O'Connor PM: UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem 273: 33455\u201333464, 1998","journal-title":"J Biol Chem"},{"key":"260334_CR29","first-page":"3248","volume":"58","author":"E Fuse","year":"1998","unstructured":"Fuse E, Tanii H, Kurata N, Kobayashi H, Shimada Y, Tamura T, Sasaki Y, Tanigawara Y, Lush RD, Headlee D, Figg WD, Arbuck SG, Senderowicz AM, Sausville EA, Akinaga S, Kuwabara T, Kobayashi S: Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. Cancer Res 58: 3248\u20133253, 1998","journal-title":"Cancer Res"},{"key":"260334_CR30","unstructured":"Senderowicz AM, Headlee D, Luch R, Sausville EA: Phase I trial of infusional UCN-01, a novel protein kinase inhibitor, in patients with refractory neoplasms. In Proc thirty-fifth Annual Meeting of the American Society of Clinical Oncology: G12, 1999"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006313611677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006313611677\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006313611677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:47:48Z","timestamp":1753818468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006313611677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["260334"],"URL":"https:\/\/doi.org\/10.1023\/a:1006313611677","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}